Pharmacist intervention reduces gastropathy risk in patients using NSAIDs
- PMID: 18932013
- DOI: 10.1007/s11096-008-9258-8
Pharmacist intervention reduces gastropathy risk in patients using NSAIDs
Abstract
Objective: To establish a detection and intervention strategy in order to reduce the number of non-steroidal anti-inflammatory drug (NSAIDs) users at risk of gastropathy from receiving either inadequate or no gastroprotection.
Setting: Community Pharmacies in Valencia, Spain.
Method: Prospective longitudinal intervention study without control group carried out by 79 Community Pharmacies. Patients over 18 who asked for any systemic NSAID were interviewed according to standard procedure. Pharmacist intervention was carried out when a patient at risk of serious NSAID-induced gastrointestinal complications due to inadequate or no gastric protection was identified. The doctor responsible was informed in order to then be able to assess the need to prescribe gastroprotection or change it if inadequate. In the case of over-the-counter (OTC) drugs, pharmacist intervention mainly involved replacing NSAIDs for safer medications.
Main outcome measure: Firstly, the number of patients who had no prescribed gastroprotection or inadequate gastroprotection was determined. Pharmacist intervention then brought about changes in pharmacotherapy in this situation.
Results: Of the 6,965 patients who asked for NSAIDs during the study period, 3,054 (43.9%) presented NSAID gastropathy risk factors. 35.6% of the latter (1,089) were not prescribed gastroprotection or were prescribed inadequate gastroprotection. Pharmacist intervention was carried out in 1,075 of these cases. On 391 occasions such risk situations were reported to doctors, who accepted pharmacist intervention on 309 occasions (79.0%) and then either prescribed gastroprotection (77% of cases); changed it (13.9%); withdrew the NSAID (5.8%) or substituted it (3.2%). 235 Pharmacist interventions took place when dispensing OTC NSAIDs.
Conclusion: Our strategy allowed us to identify a large number of patients who asked for NSAIDs in Community Pharmacies and who were at risk of NSAID gastropathy, as they received either inadequate gastroprotection or no gastroprotection whatsoever. Moreover, the pharmacist intervention carried out has reduced the number of these risk situations.
Similar articles
-
Effectiveness of interventions by community pharmacists to reduce risk of gastrointestinal side effects in nonselective nonsteroidal anti-inflammatory drug users.Pharmacoepidemiol Drug Saf. 2014 Apr;23(4):382-9. doi: 10.1002/pds.3587. Epub 2014 Feb 18. Pharmacoepidemiol Drug Saf. 2014. PMID: 24535837
-
Use of gastrointestinal prophylaxis in NSAID patients: a cross sectional study in community pharmacies.Int J Clin Pharm. 2011 Apr;33(2):155-64. doi: 10.1007/s11096-011-9490-5. Epub 2011 Mar 12. Int J Clin Pharm. 2011. PMID: 21394571
-
Non-prescription treatment of NSAID induced GORD by Australian pharmacies: a national simulated patient study.Int J Clin Pharm. 2015 Oct;37(5):851-6. doi: 10.1007/s11096-015-0129-9. Epub 2015 May 14. Int J Clin Pharm. 2015. PMID: 25972205
-
Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice.BMC Musculoskelet Disord. 2006 Oct 20;7:79. doi: 10.1186/1471-2474-7-79. BMC Musculoskelet Disord. 2006. PMID: 17054784 Free PMC article. Review.
-
Keeping kidneys safe: the pharmacist's role in NSAID avoidance in high-risk patients.J Am Pharm Assoc (2003). 2015 Jan-Feb;55(1):e15-23; quiz e24-5. doi: 10.1331/JAPhA.2015.15506. J Am Pharm Assoc (2003). 2015. PMID: 25503987 Review.
Cited by
-
The outpatient utilization of non-steroidal anti-inflammatory drugs in South Bačka District, Serbia.Int J Clin Pharm. 2011 Apr;33(2):246-51. doi: 10.1007/s11096-011-9487-0. Epub 2011 Feb 25. Int J Clin Pharm. 2011. PMID: 21744192
-
Evaluation of community pharmacists' roles in screening and communication of risks about non-steroidal anti-inflammatory drugs in Thailand.Prim Health Care Res Dev. 2018 Nov;19(6):598-604. doi: 10.1017/S1463423618000142. Epub 2018 Mar 19. Prim Health Care Res Dev. 2018. PMID: 29551098 Free PMC article.
-
Scoping review of interventions to de-implement potentially harmful non-steroidal anti-inflammatory drugs (NSAIDs) in healthcare settings.BMJ Open. 2024 Apr 17;14(4):e078808. doi: 10.1136/bmjopen-2023-078808. BMJ Open. 2024. PMID: 38631836 Free PMC article.
-
Hospital pharmacists' roles and attitudes in providing information on the safety of non-steroidal anti-inflammatory drugs in Thailand.Int J Clin Pharm. 2014 Dec;36(6):1205-12. doi: 10.1007/s11096-014-0018-7. Epub 2014 Oct 7. Int J Clin Pharm. 2014. PMID: 25288144
-
Quality of assessment and counselling offered by community pharmacists and medication sale without prescription to patients presenting with acute cardiac symptoms: a simulated client study.Eur J Clin Pharmacol. 2016 Mar;72(3):321-8. doi: 10.1007/s00228-015-1981-1. Epub 2015 Nov 23. Eur J Clin Pharmacol. 2016. PMID: 26592495
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources